article thumbnail

House Introduces Legislation Restricting Confidentiality Provisions in Settlement Agreements

Trading Secrets

introduced legislation to restrict confidentiality provisions from covering claims of discrimination, harassment, and retaliation. 8146 , appears to be a federal effort to expedite the state-level trend to exempt discrimination, harassment, and retaliation information from confidentiality restrictions.

article thumbnail

House Introduces Legislation Restricting Confidentiality Provisions in Settlement Agreements

LexBlog IP

introduced legislation to restrict confidentiality provisions from covering claims of discrimination, harassment, and retaliation. 8146 , appears to be a federal effort to expedite the state-level trend to exempt discrimination, harassment, and retaliation information from confidentiality restrictions.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

SEC Continues to Police Confidentiality Provisions for Theoretical Whistleblower Suppression

Trading Secrets

Morgan Securities, LLC (“JPMS”) for allegedly including overbroad release provisions in settlement agreements. The rule broadly prohibits any person from taking any action to prevent an individual from contacting the SEC directly to report a possible securities law. with respect to such communications.”

article thumbnail

SEC Continues to Police Confidentiality Provisions for Theoretical Whistleblower Suppression

LexBlog IP

Morgan Securities, LLC (“JPMS”) for allegedly including overbroad release provisions in settlement agreements. The rule broadly prohibits any person from taking any action to prevent an individual from contacting the SEC directly to report a possible securities law. with respect to such communications.”

article thumbnail

IPTV Piracy Lawsuit Against Datacamp Close to Settlement For Second Time

TorrentFreak

Confidentiality Agreement After a couple of weeks of relative calm, the parties agreed on a confidentiality order and from there, nothing but silence until December 2022. A status report revealed that DISH had served requests for production on DataCamp and that the company would engage in “rolling” document production.

article thumbnail

Celltrion Stelara (Ustekinumab) Settlement With J&J

LexBlog IP

It has been reported that Celltrion has finalized a settlement with Johnson & Johnson (“J&J”) in the United States relating to CT-P43, Celltrion’s ustekinumab biosimilar to J&J’s STELARA®, which would permit Celltrion to launch the product in the U.S. market on March 7, 2025, if approved by FDA.

article thumbnail

Formycon/Fresenius Kabi and Samsung Bioepis Settlements with J&J and Janssen Biotech regarding Ustekinumab

LexBlog IP

On August 7, 2023, Formycon AG and Fresenius Kabi announced that they have reached a settlement with Johnson & Johnson (“J&J”) in the United States relating to FYB202, a proposed ustekinumab biosimilar to STELARA®, marketed by J&J. Economic terms of the settlement were not disclosed in the press release.